Tab Application Banner
  • Users Online: 3457
  • Home
  • Print this page
  • Email this page
Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Login 
Year : 2009  |  Volume : 4  |  Issue : 1  |  Page : 20-24

Giant cell arteritis

UND School of Medicine and Health Sciences, Grand Forks, North Dakota, USA

Correspondence Address:
P Kaushik
UND School of Medicine and Health Sciences, Grand Forks, North Dakota, USA

Login to access the Email id

Source of Support: None, Conflict of Interest: None

Rights and PermissionsRights and Permissions

Giant cell arteritis (GCA) is probably the commonest type of large-vessel vasculitis seen in the United States (with a possible involvement of medium-sized vessels as well). The exact etiopathogenesis of GCA is still not fully understood. Clinical manifestations of GCA can be vast and confusing. Up to 22.5% patients may have a 'normal' erythrocyte sedimentation rate (ESR) before treatment. Early detection (with a high index of suspicion) with early initiation of treatment can be 'sight as well as life saving'. Treatment should not be delayed until the results of a temporal artery biopsy are obtained. Newer radiographic techniques including color-Doppler ultrasonography and contrast enhanced 3T MRA may facilitate/increase the yield; and may even obviate the need for a temporal artery biopsy (especially because temporal artery biopsy can be 'read as negative' in a significant proportion of cases). Some recent advances in genetics, pathophysiology, treatment and outcome are also reviewed in this article.

Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded47    
    Comments [Add]    

Recommend this journal